Cardiometabolic syndrome: pathophysiology and treatment (Q35209082)

7 August 2017

1 reference

title

Cardiometabolic syndrome: pathophysiology and treatment (English)

1 reference

7 August 2017

1 reference

Jonathan P Castro

1 reference

7 August 2017

Fadi A El-Atat

1 reference

7 August 2017

Samy I McFarlane

1 reference

7 August 2017

Ashish Aneja

1 reference

7 August 2017

James R Sowers

1 reference

7 August 2017

publication date

1 October 2003

1 reference

Current Hypertension Reports

7 August 2017

published in

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

7 August 2017

page(s)

393-401

1 reference

Insulin Resistance as an Independent Risk Factor for Carotid Artery Wall Intima Media Thickening in Vasospastic Angina

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11906-003-0085-Y

Impaired insulin sensitivity and maximal responsiveness in older hypertensive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-003-0085-Y

Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-003-0085-Y

Microalbuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-003-0085-Y

Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-003-0085-Y

Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-003-0085-Y

State-of-the-art-lecture: Obesity-induced hypertension: new concepts from the emerging biology of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-003-0085-Y

Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-003-0085-Y

Physiology and pathophysiology of the adipose tissue renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-003-0085-Y

Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-003-0085-Y

Insulin increases cyclic nucleotide content in human vascular smooth muscle cells: a mechanism potentially involved in insulin-induced modulation of vascular tone

21 January 2018

1 reference

12 December 2020

Weight reduction improves high blood pressure and microalbuminuria in hypertensive patients with obesity

1 reference

12 December 2020

Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids

1 reference

12 December 2020

Risk Variable Clustering in the Insulin Resistance Syndrome: The Framingham Offspring Study

1 reference

12 December 2020

Insulin resistance and cardiovascular disease

1 reference

12 December 2020

Cardiovascular morbidity and mortality associated with the metabolic syndrome

1 reference

12 December 2020

Insulin does not regulate vascular smooth muscle Na+, K(+)-ATPase activity in rabbit aorta

1 reference

12 December 2020

Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production

1 reference

12 December 2020

Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up

1 reference

12 December 2020

Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans

1 reference

12 December 2020

Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium

1 reference

12 December 2020

Is there a role for the ob gene product leptin in essential hypertension?

1 reference

12 December 2020

Regulation of the Na,K-pump in skeletal muscle

1 reference

12 December 2020

Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering

1 reference

12 December 2020

Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects

1 reference

12 December 2020

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

1 reference

12 December 2020

Effects of insulin and IGF-I on vascular smooth muscle glucose and cation metabolism

1 reference

12 December 2020

Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond

1 reference

12 December 2020

Obesity-induced hypertension. Renal function and systemic hemodynamics

1 reference

12 December 2020

Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity

1 reference

12 December 2020

Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study

1 reference

12 December 2020

Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men

1 reference

12 December 2020

The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension

1 reference

12 December 2020

Microalbuminuria: a therapeutic goal in patients with type 2 diabetes

1 reference

12 December 2020

ACE, angiotensinogen and obesity: a potential pathway leading to hypertension

1 reference

12 December 2020

Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients

1 reference

12 December 2020

Stimulation of vascular Na(+)-K(+)-ATPase activity by nitric oxide: a cGMP-independent effect

1 reference

12 December 2020

Insulin resistance: the shape of things to come.

1 reference

12 December 2020

Effect of troglitazone on fibrinolysis and activated coagulation in patients with non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Differential effect of metabolic fuels on the energy state and Na(+)-K(+)-ATPase in isolated cerebral microvessels

1 reference

12 December 2020

Reduction of Albumin Excretion Rate in Normotensive Microalbuminuric Type 2 Diabetic Patients During Long-Term Simvastatin Treatment

1 reference

12 December 2020

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

12 December 2020

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study

1 reference

12 December 2020

Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives

1 reference

12 December 2020

Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention

1 reference

12 December 2020

Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease

1 reference

12 December 2020

Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans

1 reference

12 December 2020

The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes

1 reference

12 December 2020

Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in Finland

1 reference

12 December 2020

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

12 December 2020

Resistance to Insulin-Stimulated-Glucose Uptake in Patients with Hypertension*

1 reference

12 December 2020

Update on the cardiometabolic syndrome

1 reference

12 December 2020

Improvements in blood pressure, glucose metabolism, and lipoprotein lipids after aerobic exercise plus weight loss in obese, hypertensive middle-aged men.

1 reference

12 December 2020

Adiposity, fat distribution, and cardiovascular risk

1 reference

12 December 2020

Insulin attenuates vasopressin-induced calcium transients and a voltage-dependent calcium response in rat vascular smooth muscle cells

1 reference

12 December 2020

Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system

1 reference

12 December 2020

Aldosterone in obesity

1 reference

12 December 2020

Angiotensinogen levels and obesity in four black populations. ICSHIB Investigators

1 reference

12 December 2020

Plasma leptin levels strongly correlate with plasma renin activity in patients with essential hypertension.

1 reference

12 December 2020

Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population

1 reference

12 December 2020

Obesity hypertension: role of leptin and sympathetic nervous system

1 reference

12 December 2020

Participation of PI3K and atypical PKC in Na+-K+-pump stimulation by IGF-I in VSMC.

1 reference

12 December 2020

Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity

1 reference

12 December 2020

Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk

1 reference

12 December 2020

Prevalence of insulin resistance in essential hypertension

1 reference

12 December 2020

Ins and outs of Ca2+ transport

1 reference

12 December 2020

Antihypertensive therapy and the risk of type 2 diabetes mellitus

1 reference

12 December 2020

Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease

1 reference

12 December 2020

Can reduction in hypertriglyceridaemia slow progression of microalbuminuria in patients with non-insulin-dependent diabetes mellitus?

1 reference

12 December 2020

Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study

1 reference

12 December 2020

Losartan reduces microalbuminuria in hypertensive microalbuminuric type 2 diabetics

1 reference

12 December 2020

Effect of orlistat-assisted weight loss in decreasing coronary heart disease risk in patients with syndrome X.

1 reference

12 December 2020

Effect of troglitazone on urinary albumin excretion and serum type IV collagen concentrations in Type 2 diabetic patients with microalbuminuria or macroalbuminuria

1 reference

12 December 2020

Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension

1 reference

12 December 2020

Regulation of Na+,K(+)-ATPase gene expression by insulin in vascular smooth muscle cells

1 reference

12 December 2020

10.1007/S11906-003-0085-Y

Identifiers

DOI

1 reference

7 August 2017

1 reference